Akebia Therapeutics to Present at the Jefferies London Healthcare Conference
Akebia Therapeutics (Nasdaq: AKBA) has announced its participation in the upcoming Jefferies London Healthcare Conference. CEO John Butler will deliver a presentation on Thursday, November 21 at 1:00 PM GMT. The conference is scheduled for November 19-21, 2024, in London. Interested parties can access the presentation webcast through the 'Investors' section of Akebia's website at ir.akebia.com, where it will remain available for 30 days after the event. Akebia Therapeutics focuses on improving the lives of people affected by kidney disease.
Akebia Therapeutics (Nasdaq: AKBA) ha annunciato la sua partecipazione alla prossima Jefferies London Healthcare Conference. Il CEO John Butler presenterà giovedì 21 novembre alle 13:00 GMT. La conferenza è programmata per il 19-21 novembre 2024, a Londra. Le parti interessate possono accedere alla trasmissione in diretta della presentazione attraverso la sezione 'Investitori' del sito web di Akebia all'indirizzo ir.akebia.com, dove rimarrà disponibile per 30 giorni dopo l'evento. Akebia Therapeutics si concentra sul miglioramento della vita delle persone affette da malattie renali.
Akebia Therapeutics (Nasdaq: AKBA) ha anunciado su participación en la próxima Jefferies London Healthcare Conference. El CEO John Butler realizará una presentación el jueves 21 de noviembre a la 1:00 PM GMT. La conferencia está programada para el 19-21 de noviembre de 2024, en Londres. Las partes interesadas pueden acceder a la transmisión en línea de la presentación a través de la sección 'Inversores' en el sitio web de Akebia en ir.akebia.com, donde estará disponible durante 30 días después del evento. Akebia Therapeutics se enfoca en mejorar la vida de las personas afectadas por enfermedades renales.
Akebia Therapeutics (Nasdaq: AKBA)은 다가오는 제퍼리스 런던 헬스케어 컨퍼런스에 참여한다고 발표했습니다. CEO 존 버틀러는 11월 21일 목요일 오후 1시 GMT에 발표를 할 예정입니다. 이 컨퍼런스는 2024년 11월 19일부터 21일까지 런던에서 개최됩니다. 관심 있는 사람들은 Akebia 웹사이트의 '투자자' 섹션을 통해 발표 웹캐스트에 접속할 수 있으며, 이벤트 후 30일 동안 이용 가능합니다. Akebia Therapeutics는 신장 질환에 영향을 받은 사람들의 삶을 개선하는 데 주력하고 있습니다.
Akebia Therapeutics (Nasdaq: AKBA) a annoncé sa participation à la prochaine Jefferies London Healthcare Conference. Le PDG John Butler fera une présentation le jeudi 21 novembre à 13h00 GMT. La conférence est prévue du 19 au 21 novembre 2024 à Londres. Les parties intéressées peuvent accéder au webinaire de la présentation par le biais de la section 'Investisseurs' du site web d'Akebia à l'adresse ir.akebia.com, où il sera disponible pendant 30 jours après l'événement. Akebia Therapeutics se concentre sur l'amélioration de la vie des personnes touchées par des maladies rénales.
Akebia Therapeutics (Nasdaq: AKBA) hat seine Teilnahme an der bevorstehenden Jefferies London Healthcare Conference angekündigt. CEO John Butler wird am Donnerstag, den 21. November, um 13:00 Uhr GMT eine Präsentation halten. Die Konferenz ist für den 19.-21. November 2024 in London geplant. Interessierte Parteien können über den Bereich 'Investoren' auf der Website von Akebia unter ir.akebia.com auf den Präsentations-Webcast zugreifen, der 30 Tage nach der Veranstaltung verfügbar bleiben wird. Akebia Therapeutics konzentriert sich darauf, das Leben von Menschen zu verbessern, die von Nierenerkrankungen betroffen sind.
- None.
- None.
A webcast of the presentation can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.com for 30 days following the conference.
The Jefferies London Healthcare Conference will take place November 19-21, 2024 in
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-the-jefferies-london-healthcare-conference-302301773.html
SOURCE Akebia Therapeutics, Inc.
FAQ
When is Akebia Therapeutics (AKBA) presenting at the Jefferies London Healthcare Conference 2024?
How long will the AKBA Jefferies Conference presentation webcast be available?
What dates is the Jefferies London Healthcare Conference 2024 being held?
Where can I watch Akebia Therapeutics' (AKBA) Jefferies Conference presentation?
